These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2405207)

  • 1. [Assessment of cisplatin in concurrent use with radiotherapy in esophageal carcinoma--joint research among nationwide multi-facilities, primary results. Research Committee for Radiation and Cisplatin Treatment of Esophageal Carcinoma].
    Ishikawa T; Irie G; Asakawa H; Ikeda M; Dokiya T; Morita K; Inoue T; Masuda K
    Gan No Rinsho; 1990 Jan; 36(1):1-6. PubMed ID: 2405207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiation therapy with or without cisplatin in esophageal carcinoma].
    Chatani M; Teshima T; Inoue T
    Gan No Rinsho; 1989 Dec; 35(15):1723-7. PubMed ID: 2607605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].
    Jiang YY; Wu SX; Zhang P; Xie CY; Wang J; Sun CC
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2171-4. PubMed ID: 19080664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
    Taieb S; Vaillant E; Pommier P; Bonvoisin S; Desseigne F; Morignat E; Gerard JP; Mornex F
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1048-54. PubMed ID: 10592877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of advanced esophageal cancer successfully treated by concurrent use of radiotherapy and low-dose CDDP and continuous infusion of 5-FU].
    Miyaji N; Miki T; Ito Y; Takeshita T; Churei H; Hiraki Y; Nakajo M; Fukumoto T; Aiko T; Maenohara S; Minamimagari H
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):601-4. PubMed ID: 9087295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.
    Tahara M; Ohtsu A; Hironaka S; Boku N; Ishikura S; Miyata Y; Ogino T; Yoshida S
    Jpn J Clin Oncol; 2005 Jun; 35(6):316-23. PubMed ID: 15961436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced esophageal carcinoma successfully treated with chemoradiation therapy with low-dose cisplatin and 5-fluorouracil].
    Oyama K; Hirosawa H; Ito H; Fukushima W; Masutani H; Kadoya N; Izumi R; Hirono T
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):899-903. PubMed ID: 10897218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemoradiotherapy in esophageal cancer].
    Cordiano C; Laterza E; Urso SU; Castaldini G
    Chir Ital; 1994; 46(3):11-5. PubMed ID: 8001187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined radiotherapy and chemotherapy (cisplatin, methotrexate, and peplomycin) in esophageal cancer].
    Kagami Y; Sakurai T; Nishio M; Narimatsu N; Saitoh A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Sep; 48(9):1172-6. PubMed ID: 2462208
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination of radiotherapy with cisplatin in esophageal cancer].
    Tohnosu N; Onoda S; Okuyama K; Yamamoto Y; Kimura M; Awano T; Tsukamoto S; Isono K; Ishikawa T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3169-74. PubMed ID: 3777954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
    Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
    Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I study of CM-Na combined with concurrent radiochemotherapy for advanced esophageal carcinoma].
    Cai L; Liu MZ; Gu MF; Liu H; Chen EC; Hu YH; Lin HX; Wang HY; Huang Y; Li QQ; Cui NJ; Rong TH
    Ai Zheng; 2005 May; 24(5):582-6. PubMed ID: 15890102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local failure-related factors of esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Liu H; Li QQ; Cai L; Huang Y; Lin HX; Wang HY; Liu H; Cui NJ
    Ai Zheng; 2005 Apr; 24(4):498-501. PubMed ID: 15820078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.